Rocuronium infusion requirements and plasma concentrations at constant levels of neuromuscular paralysis during three phases of liver transplantation

Journal of Clinical Anesthesia

Volumn 15, Issue 4, 2003, Pages 257-266

  Gao, Ling ^a   Ramzan, Iqbal ^a   Baker, Barry ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Infusion requirements; Liver transplantation; Plasma concentrations; Rocuronium

Indexed keywords

MORPHINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INFUSION; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; NEUROMUSCULAR BLOCKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION;

EID: 0041848430     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(03)00061-8     Document Type: Article

References (27)

1. van Miert M.M., Eastwood N.B., Boyd A.H., Parker C.J., Hunter J.M. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol. 44:1997;139-144.
2. Magorian T., Wood P., Caldwell J., et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 80:1995;754-759.
3. Khalil M., D'Honneur G., Duvaldestin P., Slavov V., De Hys C., Gomeni R. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology. 80:1994;1241-1247.
4. Gao L., Ramzan I., Baker B. Rocuronium plasma concentrations during three phases of liver transplantation relationship with early postoperative graft liver function . Br J Anaesth. 88:2002;764-770.
5. Wierda J.M., Proost J.H., Schiere S., Hommes F.D. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans. Eur J Anaesthesiol Suppl. 9:1994;66-74.
6. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
7. Gao L., Ramzan I., Baker B. Gas chromatographic-mass spectrometric assay for rocuronium with potential for quantifying its metabolite, 17-desacetylrocuronium, in human plasma. J Chromatogr B Biomed Sci Appl. 757:2001;207-214.
8. O'Kelly B., Jayais P., Veroli P., Lhuissier C., Ecoffey C. Dose requirements of vecuronium, pancuronium, and atracurium during OLT. Anesth Analg. 73:1991;794-798.
9. Fisher D.M., Ramsay M.A., Hein H.A., et al. Pharmacokinetics of rocuronium during the three stages of liver transplantation. Anesthesiology. 86:1997;1306-1316.
10. Pittet J.F., Morel D.R., Mentha G., et al. Vecuronium neuromuscular blockade reflects liver function during hepatic autotransplantation in pigs. Anesthesiology. 81:1994;168-175.
11. Pittet J.F., Tassonyi E., Schopfer C., et al. Dose requirements and plasma concentrations of pipecuronium during bilateral renal exclusion and OLT in pigs. Br J Anaesth. 65:1990;779-785.
12. Lukin C.L., Hein H.A., Swygert T.H., et al. Duration of vecuronium-induced neuromuscular block as a predictor of liver allograft dysfunction. Anesth Analg. 80:1995;526-533.
13. Kelley S.D., Cauldwell C.B., Fisher D.M., Lau M., Sharma M.L., Weisiger R.A. Recovery of hepatic drug extraction after hypothermic preservation. Anesthesiology. 82:1995;251-258.
14. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation. 55:1993;807-813.
15. Viby-Mogensen J., Engbaek J., Eriksson L.I., et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand. 40:1996;59-74.
16. Miller R.D., Van Nyhuis L.S., Eger E.I. 2nd, Way W.L. The effect of acid-base balance on neostigmine antagonism of d-tubocurarine-induced neuromuscular blockade. Anesthesiology. 42:1975;377-383.
17. Funk D.I., Crul J.F., Pol F.M. Effects of changes in acid-base balance on neuromuscular blockade produced by ORG-NC 45. Acta Anaesthesiol Scand. 24:1980;119-124.
18. Hernandez-Palazon J., Tortosa J.A., Martinez-Lage J.F., Perez-Ayala M. Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy. J Neurosurg Anesthesiol. 13:2001;79-82.
19. Skinner H.J., Girling K.J., Whitehurst A., Nathanson M.H. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium. Br J Anaesth. 82:1999;542-545.
20. Fu W., Klein K.W., White P.F., et al. Rapacuronium recovery characteristics and infusion requirements during inhalation versus propofol-based anaesthesia. Br J Anaesth. 85:2000;302-305.
21. Wulf H., Ledowski T., Linstedt U., Proppe D., Sitzlack D. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth. 45:1998;526-532.
22. Wulf H., Kahl M., Ledowski T. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i. v. anaesthesia. Br J Anaesth. 80:1998;308-312.
23. Hans P., Brichant J.F., Hubert B., Dewandre P.Y., Lamy M. Influence of induction of anaesthesia on intubating conditions one minute after rocuronium administration comparison of ketamine and thiopentone . Anaesthesia. 54:1999;276-279.
24. Hodges U.M. Vecuronium infusion requirements in paediatric patients in intensive care units the use of acceleromyography . Br J Anaesth. 76:1996;23-28.
25. McCluskey A., Meakin G., Hopkinson J.M., Baker R.D. A comparison of acceleromyography and mechanomyography for determination of the dose-response curve of rocuronium in children. Anaesthesia. 52:1997;345-349.
26. Pittet J.F., Tassonyi E., Schopfer C., et al. Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of OLT in pigs. Anesthesiology. 72:1990;145-152.
27. Proost J.H., Eriksson L.I., Mirakhur R.K., Roest G., Wierda J.M. Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth. 85:2000;717-723.